Catalyst Wire Dossier Catalyst Wire Dossier

Qulipta (atogepant)

atogepant · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qulipta (atogepant), covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine [Phase 3]

See pricing